Cancer in General Responders Participating in World Trade Center Health Programs, 2003–2013
-
2020/02/01
-
Details
-
Personal Author:Crane MA ; Dasaro CR ; Harrison DJ ; Lucchini RG ; Luft BJ ; Moline JM ; Sacks HS ; Shapiro MZ ; Teitelbaum SL ; Thanik ES ; Todd AC ; Udasin IG ; Wallenstein SR
-
Description:Background: Following the September 11, 2001, attacks on the World Trade Center (WTC), thousands of workers were exposed to an array of toxins known to cause adverse health effects, including cancer. This study evaluates cancer incidence in the WTC Health Program General Responder Cohort occurring within 12 years post exposure. Methods: The study population consisted of 28 729 members of the General Responder Cohort enrolled from cohort inception, July 2002 to December 31, 2013. Standardized incidence ratios (SIRs) were calculated with cancer case inclusion and follow-up starting post September 11, 2001 (unrestricted) and, alternatively, to account for selection bias, with case inclusion and follow-up starting 6 months after enrollment in the WTC Health Program (restricted). Case ascertainment was based on linkage with six state cancer registries. Under the restricted criterion, hazard ratios were estimated using multivariable Cox proportional hazards models for all cancer sites combined and for prostate cancer. Results: Restricted analyses identified 1072 cancers in 999 responders, with elevations in cancer incidence for all cancer sites combined (SIR = 1.09, 95% confidence interval [CI] = 1.02 to 1.16), prostate cancer (SIR = 1.25, 95% CI = 1.11 to 1.40), thyroid cancer (SIR = 2.19, 95% CI = 1.71 to 2.75), and leukemia (SIR = 1.41, 95% CI = 1.01 to 1.92). Cancer incidence was not associated with any WTC exposure index (composite or individual) for all cancer sites combined or for prostate cancer. Conclusion: Our analyses show statistically significant elevations in cancer incidence for all cancer sites combined and for prostate and thyroid cancers and leukemia. Multivariable analyses show no association with magnitude or type of exposure. [Description provided by NIOSH]
-
Subjects:
-
Keywords:
-
ISSN:2515-5091
-
Document Type:
-
Funding:
-
Genre:
-
Place as Subject:
-
CIO:
-
Topic:
-
Location:
-
Volume:4
-
Issue:1
-
NIOSHTIC Number:nn:20068361
-
Citation:JNCI Cancer Spectr 2020 Feb; 4(1):pkz090
-
Contact Point Address:M. Z. Shapiro, MS, Department of Environmental Medicine and Public Health, Box 1057, Icahn School of Medicine at Mount Sinai, 1 Gustave L. Levy Place, New York, NY 10029
-
Email:moshe.shapiro@mssm.edu
-
Federal Fiscal Year:2020
-
Performing Organization:State University of New York Stony Brook
-
Peer Reviewed:True
-
Start Date:20040715
-
Source Full Name:JNCI Cancer Spectrum
-
End Date:20110630
-
Collection(s):
-
Main Document Checksum:urn:sha-512:5f5738e448fadb67651a473a0a52d6d49efdcc33625427b72948af77468279cb96cc4141a44603a6816c606cdec9526241f717313427ddb281015aab00c127ca
-
Download URL:
-
File Type:
ON THIS PAGE
CDC STACKS serves as an archival repository of CDC-published products including
scientific findings,
journal articles, guidelines, recommendations, or other public health information authored or
co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
You May Also Like